Indication

E. coli osteomyelitis

E. Read more about E. coli osteomyelitis

50 drugs 38 manufacturers

Advertisement

Drugs that treat it

Common E. coli osteomyelitis therapies.

Showing 19–27 of 50 drugs

Filter & compare in the drug finder →Opens the drug finder with E. coli osteomyelitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About E. coli osteomyelitis.

E.

coli osteomyelitis is an inflammatory bone and bone marrow infection caused by the Gram-negative bacillus *Escherichia coli*.

It predominantly affects the musculoskeletal system, most commonly involving the vertebral column, long bones, or pelvic bones.

While relatively uncommon compared to Gram-positive bone infections, it frequently arises in elderly individuals, patients with diabetes mellitus, or immunocompromised hosts.

Pathophysiologically, it typically develops via hematogenous dissemination—often secondary to antecedent bacteremia originating from a urinary tract or intra-abdominal focus—or through contiguous spread from adjacent soft-tissue infections or surgical inoculation.

Hallmark clinical features include localized bone pain, tenderness, erythema, fever, progressive osseous destruction, and potentially systemic signs of infection or abscess formation.

Personalize your experience

Follow E. coli osteomyelitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it